Deutsche Biotech Innovativ AG

DUSE:DBI Voorraadrapport

Marktkapitalisatie: €1.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Deutsche Biotech Innovativ Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Bernd Wegener

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

What Kind Of Investors Own Most Of Deutsche Biotech Innovativ AG (DUSE:DBI)?

Feb 17
What Kind Of Investors Own Most Of Deutsche Biotech Innovativ AG (DUSE:DBI)?

Deutsche Biotech Innovativ (DUSE:DBI) Is In A Good Position To Deliver On Growth Plans

Dec 02
Deutsche Biotech Innovativ (DUSE:DBI) Is In A Good Position To Deliver On Growth Plans

CEO

Bernd Wegener (77 yo)

no data

Tenure

Dr. Bernd Wegener, FRICS, serves as the Chairman of Management Board and Chief Executive Officer at Deutsche Biotech Innovativ AG. Dr. Wegener served as Chairman of the Supervisory Board of Adrenomed AG un...